Company Search:
Advanced Search
Sponsored Links
Changsheng Bio-technology Co Ltd Company Snapshot
Changsheng Bio-technology Co Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Changsheng Bio-technology Co Ltd with three other companies in this sector in China: Beijing SL Pharmaceutical Co Ltd (2016 sales of 1.01 billion Chinese Renmimbi [US$156.95 million] of which 98% was Pharmaceuticals Industry), Boya Bio-pharmaceutical Group Co Ltd (946.57 million Chinese Renmimbi [US$147.12 million] of which 56% was Blood Plasma), and Tianjin Ringpu Bio-Technology Co Ltd (969.68 million Chinese Renmimbi [US$150.71 million] of which 63% was Veterinary Biological Products).

Sales Analysis. During the year ended December of 2016, sales at Changsheng Bio-technology Co Ltd were 1.02 billion Chinese Renmimbi (US$158.20 million). This is an increase of 28.0% versus 2015, when the company's sales were 795.33 million Chinese Renmimbi. Sales of Vaccine Sales saw an increase of 28.5% in 2016, from 789.72 million Chinese Renmimbi to 1.01 billion Chinese Renmimbi. Not all segments of Changsheng Bio-technology Co Ltd experienced an increase in sales in 2016: sales of Others fell 49.4% to 2.94 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Changsheng Bio-technology Co Ltd
  Stock Performance Chart for Changsheng Bio-technology Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 14.02
(Figures in Chinese Renmimbi)
1 Week -4.8%   13 Weeks -3.4%  
4 Weeks -7.2%   52 Weeks -16.3%  
Changsheng Bio-technology Co Ltd Key Data:
  Ticker: 002680 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 1,017,897,199
(Year Ending Jan 2017).
Employees: 1,059
  Currency: Chinese Renmimbi Market Cap: 13,651,139,100
  Fiscal Yr Ends: December Shares Outstanding: 973,690,378
  Share Type: A Gu Closely Held Shares: 737,429,073
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.